Copper Transport Mechanisms in Human Health

Copper is an essential micronutrient that supports diverse physiological processes through precisely regulated transport, distribution and excretion pathways. Dietary copper is imported into cells primarily via the high-affinity copper transporter CTR1 at the plasma membrane. Once inside, copper ions are escorted by specialised chaperones, notably Atox1, to intracellular destinations including the secretory pathway, mitochondria and enzymes in the cytosol. Copper-transporting ATPases ATP7A and ATP7B mediate delivery of copper to cuproenzymes and export of excess metal to maintain homeostatic levels. This balanced network underpins redox reactions, collagen cross-linking, neurotransmitter synthesis and iron metabolism. Disruption of any component can result in deficiency or overload, giving rise to inherited disorders such as Menkes and Wilson diseases, contributing to neurodegenerative conditions and impairing immune function. In the central nervous system, copper flux across the blood–brain barrier, synaptic release and subcellular compartmentalisation finely tune neuronal signalling and prevent toxicity. Emerging insights into transporter trafficking, chaperone redox regulation and novel cell-death pathways underscore the global significance of copper homoeostasis and hint at therapeutic avenues for metabolic and age-associated diseases.

Research from Nature Portfolio

A foundational study demonstrated that neuronal differentiation triggers redox changes in glutathione that activate the copper chaperone Atox1 and upregulate ATP7A expression. This coordinated response enhances copper flux through the secretory pathway, ensuring balanced cytosolic copper levels and increased supply of the metal to newly expressed copper-dependent enzymes. The work provides a direct link between cellular redox state and copper compartmentalisation in neurons, revealing a rapid adaptive mechanism crucial for normal brain development and function.

Copper Transport Mechanisms in Human Health publication trend

The graph below shows the total number of articles in copper transport mechanisms in human health across all publications each year (not limited to Nature Index journals).

Technical terms

High-affinity copper transporter 1 (CTR1): Primary plasma membrane protein mediating cellular copper uptake through a specific transport channel.

Copper-transporting ATPases (ATP7A and ATP7B): P-type ATPases that deliver copper to secretory pathway enzymes and mediate copper efflux to prevent toxicity.

Copper chaperone (Atox1): Small cytosolic protein that binds copper ions and transfers them to ATP7A and ATP7B for enzyme metallation and detoxification.

Cuproptosis: A form of copper-induced regulated cell death involving mitochondrial protein aggregation distinct from apoptosis or ferroptosis.

References

1. Neuronal differentiation is associated with a redox-regulated increase of copper flow to the secretory pathway. Nature Communications (2016).
2. Copper homeostasis and cuproptosis in central nervous system diseases. Cell Death & Disease (2024).
3. Cellular mechanisms of copper neurotoxicity in human, differentiated neurons. Archives of Toxicology (2024).
4. Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications. International Journal of Molecular Sciences (2020).